Food Policy Is Evolving Quickly. 7 Signals to Watch.

Food policy is getting more attention in Washington, and the direction is becoming clearer. A recent House Energy & Commerce Subcommittee hearing, “Healthier America: Legislative Proposals on the Regulation and Oversight of Food,” focused on individual bills, but the broader signal was the trajectory: greater scrutiny of ingredients, increased emphasis on labeling as a public health tool, and continued focus on infants, children, and other vulnerable populations. IFT submitted comments in response to the hearing that outline key considerations for strengthening food safety, transparency, and science-based policy decisions (read IFT’s comments on the hearing).

The hearing also reflects a broader federal reset. Across FDA, USDA, HHS, and Congress, there is increasing activity around how food safety is evaluated, how “healthy” is defined, how nutrition information is communicated, and how public confidence in the food system is strengthened.

Here are seven signals from the hearing that are worth watching.

Food Chemicals and the Future of GRAS

Momentum is building to revisit how food ingredients and chemicals are reviewed in the United States. Several proposals point to bipartisan interest in more transparency and a more consistent approach, particularly around generally recognized as safe (GRAS) substances and post-market review (see IFT’s earlier comments on FDA post-market review). This aligns with FDA’s stated 2026 Human Foods Program priorities, including ingredient oversight and increased transparency for ingredients already in the food supply.

Related:

• GRAS Overview
• Revisiting GRAS: Getting FDA’s Post-Market Review Right

Labeling Is Becoming a Frontline Policy Tool

Labeling is being treated less like a technical compliance issue and more like a primary policy tool. The hearing included proposals that address front-of-pack information, readability, date labeling, and product identity. FDA has separately identified front-of-package nutrition labeling as a 2026 priority, and the Dietary Guidelines for Americans will continue to shape how “healthy” is communicated in both policy and the marketplace.

Congress Is Putting Children and Other Vulnerable Populations at the Center

Protections for children and other vulnerable populations were a clear throughline. The hearing covered issues ranging from baby food contaminants and infant formula modernization to caffeine exposure and allergen disclosure. This emphasis points toward a more risk-based approach, with more attention on products and populations where the potential for harm is greater.

Additives, Dyes, and Ultra-Processed Foods Remain in the Spotlight

Synthetic dyes, additives, and ultra-processed foods continue to draw attention, and that focus showed up again here. The hearing reflects a broader shift in federal rhetoric and planning around chronic disease, ingredient safety, and food processing. In other words, the hearing is reinforcing the current policy trajectory—not creating it. Much of this activity is being driven by public concern, and that influence is increasingly intersecting with traditional risk-based approaches in ways that are shaping federal priorities. FDA’s 2026 priorities include reducing reliance on petroleum-based dyes, reviewing certain additives, and examining the role of ultra-processed foods in diet-related disease, an area that continues to be explored in the scientific literature.

Related:

• Defining Ultra-Processed Foods
• Food Additives Toolkit

Don't Miss at IFT FIRST

Continue this conversation at IFT FIRST Annual Event and Expo in July, where policy, trust, and compliance take center stage:

Regulations on Ultra-Processed Foods: Exploring the Impact on the Global Food Industry (Monday, July 13, 2:15–3 p.m.)

Digital Traceability: Strengthening Risk Management and Supply-Chain Resilience (Tuesday, July 14, 12:30–12:50 p.m.)

Assessing AI Tools for High-Risk Food Safety and Regulatory Decisions (Wednesday, July 15, 11–11:45 a.m.)

Register for IFT FIRST

FDA Capacity and Coordination Are Part of the Story Too

Several proposals also raise a more operational question: whether FDA has the tools, data infrastructure, budget, and coordination it needs to oversee a modern food system. Bills related to data sharing, inspections, certifications, and human foods oversight align with FDA’s emphasis on strengthening operational capacity, including more robust oversight systems and greater coordination with state inspection resources.

Agriculture and Market Integrity Concerns Are Woven Throughout

Although the hearing focused on FDA-regulated issues, several proposals have direct implications for agriculture and food markets. Topics such as honey authenticity, seafood imports, orange juice, dairy terminology, and standards of identity show how labeling and product integrity debates can also function as competitiveness and trade issues. These are not just consumer-information questions; they can influence market access, category definitions, and how the line is drawn between innovation and imitation.

Supplements Remain Part of the Broader Oversight Debate

Dietary supplements remain part of the broader oversight discussion. The proposals discussed point to ongoing concerns around transparency, listing requirements, and consistent national rules. Even within a distinct regulatory framework, the underlying goal is similar: clearer visibility into what is on the market and a more predictable approach to oversight for consumers and industry.

Why This Matters Beyond the Hearing

Taken together, these proposals fit within a broader federal reset on food, nutrition, and agriculture policy. FDA’s Human Foods Program has prioritized ingredient review reform, front-of-package labeling, infant formula nutrient review, reducing exposure to contaminants, and increased scrutiny of ultra-processed foods. At the same time, USDA and HHS have released the 2025–2030 Dietary Guidelines for Americans, which will influence how healthy eating is defined and communicated across federal programs and the marketplace.

The result is a policy environment where congressional legislation, agency priorities, nutrition guidance, and agricultural interests are moving on parallel tracks.

Bottom Line

This hearing underscored that food policy is taking center stage in Washington. For food scientists, researchers, advocates, and policymakers, the key takeaway is not any single bill—it is the direction of travel. Expect more scrutiny, more transparency expectations, and continued pressure to connect food regulation with public health outcomes.

The hearing covered a broad set of legislative proposals addressing food safety, labeling, ingredients, and FDA oversight. For the full list of bills discussed, review the full hearing materials.

Join the Community Conversation

IFT is hosting an interactive Community Conversation on Wednesday, June 17, from 12–1 p.m. CT, to break down the policy trajectory emerging from the hearing and discuss what it could mean in practice. The Community Conversation is free and open to the public. Register today.